An integrated multi-omics analysis identifies prognostic molecular subtypes of non-muscle-invasive bladder cancerSia V. Lindskrog, Lars Dyrskjøt, Mateo Sokač et al.|Nature Communications|2021Cited by 381
Molecular correlates of cisplatin-based chemotherapy response in muscle invasive bladder cancer by integrated multi-omics analysisAnn Taber, Lars Dyrskjøt, Emil Christensen et al.|Nature Communications|2020Cited by 216
Elevated T-cell Exhaustion and Urinary Tumor DNA Levels Are Associated with Bacillus Calmette-Guérin Failure in Patients with Non–muscle-invasive Bladder CancerTrine Strandgaard, Lars Dyrskjøt, Sia V. Lindskrog et al.|European Urology|2022Cited by 74
Comprehensive genomic characterization of early-stage bladder cancerFrederik Prip, Lars Dyrskjøt, Philippe Lamy et al.|Nature Genetics|2025Cited by 30
An integrated multi-omics analysis identifies clinically relevant molecular subtypes of non-muscle-invasive bladder cancerSia V. Lindskrog, Lars Dyrskjøt, Frederik Prip et al.|medRxiv|2020Cited by 10